Promethazine Codeine Actavis Discontinued

Promethazine Codeine Actavis Discontinued, In April 2014, Actavis, a pharmaceutical company, made the decision to cease production of its Promethazine Codeine cough syrup. This move was prompted by increasing concerns over the product’s misuse, particularly in recreational settings.

Reasons for Discontinuation

Originally intended as a prescription medication to treat coughs and cold symptoms, the syrup contains promethazine, an antihistamine, and codeine, an opioid. However, it gained notoriety for its misuse in concoctions like “Sizzurp” or “Lean,” often mixed with soda or candy to enhance its effects. Such misuse was glamorized in popular culture, with celebrities like Justin Bieber and Soulja Boy reportedly associated with its recreational use .

The widespread abuse and the negative attention it garnered led Actavis to halt its production. A company representative stated that the decision was driven by the product’s association with unlawful and dangerous use, which contradicted its intended medical purpose .

Impact and Aftermath

Following the discontinuation, the street value of Actavis’s Promethazine Codeine syrup reportedly surged, reflecting its high demand in illicit markets . Additionally, counterfeit versions of the syrup began to emerge, posing further risks to public health .

In India, similar concerns have led the government to consider banning certain codeine-based syrups, including those combined with promethazine, to curb their misuse .

Alternatives and Recommendations

For individuals seeking alternatives to manage cough and cold symptoms, other medications are available. However, it’s crucial to consult healthcare professionals before switching to or starting any new medication to ensure safety and efficacy.

The discontinuation of Actavis’s Promethazine Codeine syrup underscores the importance of monitoring prescription medications and addressing their potential for misuse.